qXR-CTR vs AI-ECG Platform
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your primary need is an automated, AI-driven solution for quickly assessing heart size and potential heart failure risk directly from chest X-ray images. This tool is ideal for radiology departments or cardiology practices looking to streamline initial cardiac screening and identify patients who may require further investigation based on an elevated cardiothoracic ratio.
View qXR-CTR →Choose AI-ECG Platform if…
Choose AI-ECG Platform if you require an AI-powered system for rapid and highly accurate interpretation of 12-lead resting ECGs, providing detailed diagnoses of a wide range of cardiovascular conditions. This platform is best suited for cardiology, emergency medicine, or internal medicine settings where quick and precise identification of arrhythmias, myocardial ischemia, or infarction from electrical heart activity is critical.
View AI-ECG Platform →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | AI-ECG Platform |
|---|---|---|
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | On-premise (AI-ECG Workstation), web-based (Management Portal), and client-based (AI-ECG Diagnostic Client). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
qXR-CTRTool A, qXR-CTR, as part of the broader qXR suite, offers a comprehensive user experience tailored for radiology workflows, including a DICOM viewer, worklist management, AI overlays, and mobile/desktop access via the Qure.ai App. While Tool B provides a dedicated diagnostic client and management portal for ECGs, Tool A's features suggest a more integrated and feature-rich interface for its specific domain.
Clinical Value
AI-ECG PlatformBoth tools are FDA-cleared and offer significant clinical utility. However, Tool B, the AI-ECG Platform, provides a broader diagnostic scope for 12-lead ECGs, claiming over 95% accuracy in diagnosing a wide range of major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, and supports 104 diagnostic classifications. Tool A primarily focuses on automating CTR measurement and broader chest X-ray findings for heart failure, which is valuable but less comprehensive in its diagnostic output compared to Tool B's detailed ECG analysis.
Pricing & Value
TieBoth qXR-CTR and the AI-ECG Platform require direct contact for pricing, and neither publicly discloses their pricing details. Without transparent pricing information, it is impossible to conduct a head-to-head comparison of their value propositions based on cost.
Enterprise Readiness
qXR-CTRTool A explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), along with support for a broad range of healthcare data standards including DICOM, HL7 v2, FHIR, SNOMED CT, and ICD-10. While Tool B demonstrates strong interoperability with various ECG machines and data formats (HL7 aECG, DICOM ECG, SCP ECG, MFER ECG), its HIPAA and BAA compliance are only indicated as 'likely' in the provided facts, making Tool A's explicit compliance and broader data standard support more robust for enterprise deployment.
Innovation
AI-ECG PlatformBoth tools leverage AI innovatively. Tool A automates CTR measurement and offers multi-finding detection and workflow optimization for chest X-rays. Tool B's AI-ECG Platform provides a comprehensive, highly accurate (over 95%), and rapid (approx. 3 seconds) diagnostic system for 12-lead ECGs, is hardware independent, supports numerous diagnostic classifications, and includes a component (OmniECG) described as the first electrocardiograph embedded with an AI-ECG module. This combination of broad diagnostic capability, speed, accuracy, and pioneering hardware integration gives Tool B a slight edge in innovation.
Support & Docs
qXR-CTRTool A, through Qure.ai, explicitly offers a 'Qure.ai App User's Manual,' 'Gateway User Manual,' and 'Platform API' documentation, indicating a structured and comprehensive approach to user and developer support. While Tool B's components imply the existence of user documentation, specific manuals or dedicated support resources are not as clearly highlighted or detailed in the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | AI-ECG Platform |
|---|---|---|
| Name | qXR-CTR | AI-ECG Platform |
| Company | Qure.ai Technologies | Shenzhen Carewell Electronics Co., Ltd. |
| Primary Function | AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. | FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy. |
| Target Modality/Input | Chest X-ray images | 12-lead resting ECGs |
| Key Output/Analysis | Automated measurement of cardiothoracic ratio (CTR), assessment of heart size and potential heart failure risk. | AI-powered automatic ECG analysis and diagnosis, interpretation of 12-lead resting ECGs, diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and AI-ECG Platform.